Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Elizaveta V. Divisenko"'
Autor:
Nadezhda A. Kuznetsova, Darya A. Ogarkova, Vladimir A. Gushchin, Natalya A. Antipyat, Valeria V. Bacalin, Olga A. Burgasova, Lyudmila A. Vasilchenko, Alexey A. Samkov, Yana V. Simakova, Elizaveta V. Divisenko, Andrei E. Siniavin, Artem P. Tkachuk, Liudmila V. Kolobukhina, Elena V. Shidlovskaya, Igor N. Tyurin, Irina S. Kruzhkova, Vladimir I. Zlobin, Maria A. Nikiforova, Mikhail A. Odnoralov, Alexander L. Gintsburg
Publikováno v:
Вопросы вирусологии, Vol 68, Iss 2, Pp 105-116 (2023)
Introduction. The study of the mechanisms of transmission of the SARS-CoV-2 virus is the basis for building a strategy for anti-epidemic measures in the context of the COVID-19 pandemic. Understanding in what time frame a patient can spread SARS-CoV-
Externí odkaz:
https://doaj.org/article/ca7fc81b864c43e3a0e2e33c31fef919
Autor:
Denis A. Kleymenov, Evgeniia N. Bykonia, Liubov I. Popova, Elena P. Mazunina, Vladimir A. Gushchin, Liudmila V. Kolobukhina, Olga A. Burgasova, Irina S. Kruzhkova, Nadezhda A. Kuznetsova, Elena V. Shidlovskaya, Elizaveta V. Divisenko, Andrei A. Pochtovyi, Valeria V. Bacalin, Svetlana V. Smetanina, Artem P. Tkachuk, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine release can expand our understanding of the initial stages of disease devel
Externí odkaz:
https://doaj.org/article/447677bb15474989b59f770f789a736f
Autor:
Vladimir A. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, Darya A. Ogarkova, Ivan Y. Tarnovetskii, Elizaveta D. Belyaeva, Elizaveta V. Divisenko, Lyudmila A. Vasilchenko, Elena V. Shidlovskaya, Nadezhda A. Kuznetsova, Artem P. Tkachuk, Egor A. Slutskiy, Gleb I. Speshilov, Andrei G. Komarov, Alexander N. Tsibin, Vladimir I. Zlobin, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 14670 (2022)
Findings collected over two and a half years of the COVID-19 pandemic demonstrated that the level immunity resulting from vaccination and infection is insufficient to stop the circulation of new genetic variants. The short-term decline in morbidity w
Externí odkaz:
https://doaj.org/article/a226fa3edd7042e08145c166365a12a6
Autor:
Elena V. Shidlovskaya, Nadezhda A. Kuznetsova, Elizaveta V. Divisenko, Maria A. Nikiforova, Andrei E. Siniavin, Daria A. Ogarkova, Aleksandr V. Shagaev, Maria A. Semashko, Artem P. Tkachuk, Olga A. Burgasova, Vladimir A. Gushchin
Publikováno v:
Viruses, Vol 13, Iss 10, p 2012 (2021)
The search for effective methods to detect patients who excrete a viable virus is one of the urgent tasks of modern biomedicine. In the present study, we examined the diagnostic value of two antigen tests, BIOCREDIT COVID-19 Ag (RapiGEN Inc., Anyang,
Externí odkaz:
https://doaj.org/article/0fc08181fbce489e8c304f8e54bc5d80
Autor:
Dmitry S. Karpov, Anna V. Goncharenko, Evgenii V. Usachev, Daria V. Vasina, Elizaveta V. Divisenko, Yaroslava M. Chalenko, Andrei A. Pochtovyi, Roman S. Ovchinnikov, Valentin V. Makarov, Sergei M. Yudin, Artem P. Tkachuk, Vladimir A. Gushchin
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 21, p 11657 (2021)
Approximately 1/6 of humanity is at high risk of experiencing cholera epidemics. The development of effective and safe vaccines against Vibrio cholerae, the primary cause of cholera, is part of the public health measures to prevent cholera epidemics.
Externí odkaz:
https://doaj.org/article/796c770d9b3442c18ad01745fc78b4dc
Autor:
Galya V, Klink, Ksenia, Safina, Elena, Nabieva, Nikita, Shvyrev, Sofya, Garushyants, Evgeniia, Alekseeva, Andrey B, Komissarov, Daria M, Danilenko, Andrei A, Pochtovyi, Elizaveta V, Divisenko, Lyudmila A, Vasilchenko, Elena V, Shidlovskaya, Nadezhda A, Kuznetsova, Andrei E, Samoilov, Alexey D, Neverov, Anfisa V, Popova, Gennady G, Fedonin, Vasiliy G, Akimkin, Dmitry, Lioznov, Vladimir A, Gushchin, Vladimir, Shchur, Georgii A, Bazykin
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
BackgroundDelta has outcompeted most preexisting variants of SARS-CoV-2, becoming the globally predominant lineage by mid-2021. Its subsequent evolution has led to emergence of multiple sublineages, many of which are well-mixed between countries.AimH
Autor:
D. A. Kleymenov, Anna V. Kovyrshina, Nadezhda L. Lubenets, Natalia A. Nikitenko, Sergei V. Borisevich, Alexander S. Semikhin, Elizaveta A. Tokarskaya, Daria M. Grousova, Andrey Pochtovyi, M M Shmarov, Dmitry V. Shcheblyakov, Olga Popova, Shchetinin Am, Tatiana A Ozharovskaya, Andrey Komissarov, Evgeniia N. Bykonia, Alina S. Dzharullaeva, Dmitry Lioznov, Alexander L. Gintsburg, Artem P. Tkachuk, A. I. Tukhvatulin, Denis Y. Logunov, Nadezhda P. Kuznetsova, Liubov I. Popova, Olga V. Zubkova, Inna V. Dolzhikova, Lyudmila Vasilchenko, Elena V. Shidlovskaya, Alina S. Erokhova, E. P. Mazunina, Boris S. Naroditsky, Alexander Tsybin, Elizaveta V. Divisenko, Vladimir A. Gushchin, Daria Danilenko, Fatima M. Izhaeva
ObjectivesVaccination remains the most effective response to the COVID-19 pandemic. Most vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, since, on the one hand, they simplify the vaccination program, make it mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f145807fe93e4a55dadded1a8a6b758
https://doi.org/10.1101/2021.10.08.21264715
https://doi.org/10.1101/2021.10.08.21264715
Autor:
Artem P. Tkachuk, Daria A. Ogarkova, Elena V. Shidlovskaya, Andrei E. Siniavin, Olga A. Burgasova, Maria A. Semashko, Maria A. Nikiforova, Nadezhda A. Kuznetsova, Elizaveta V. Divisenko, Vladimir A. Gushchin, Aleksandr V. Shagaev
The search for effective methods to detect patients who excrete a viable virus is one of the urgent tasks of modern biomedicine. In the present study, we examined the diagnostic value of two antigen tests BIOCREDIT COVID-19 Ag (RapiGEN Inc., Korea) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::844468e40f3bd44a13f2ce8493e2d391
https://doi.org/10.1101/2021.03.10.21252667
https://doi.org/10.1101/2021.03.10.21252667
Autor:
Ludmila V. Kolobukhina, Elizaveta V. Divisenko, Nadezhda A. Kuznetsova, Artem P. Tkachuk, Andrei A. Pochtovyi, Daria V. Vasina, Alexander L. Gintsburg, Vladimir A. Gushchin, Olga A. Burgasova, Daria D. Kustova
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 18
Issue 17
International Journal of Environmental Research and Public Health, Vol 18, Iss 9042, p 9042 (2021)
Volume 18
Issue 17
International Journal of Environmental Research and Public Health, Vol 18, Iss 9042, p 9042 (2021)
The SARS-CoV-2 pandemic remains a global health issue for several reasons, such as the low vaccination rates and a lack of developed herd immunity to the evolution of SARS-CoV-2, as well as its potential inclination to elude neutralizing antibodies.